Tyler Ellis Papp

10PUBLICATIONS
80CO-AUTHORS
Medical devicesPredictive and prognostic markersNanometrologySurface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 13, 2026
Targeted LNP-mediated delivery of VE-cadherin mRNA reduces vascular hyperpermeability in vivo.

Lanfranco Leo, Tyler Ellis Papp, Chia-Ching Chen

|Feb 13, 2026
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.

Khuloud Bajbouj, Zebin Xiao, Leslie Todd

|Feb 09, 2026
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering.

Jianhao Zeng, Tyler Ellis Papp, Awurama Akyianu

|Jan 21, 2026
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

|Aug 11, 2025
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape.

Serena Omo-Lamai, Yufei Wang, Manthan N Patel

|Mar 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

Pageof 2

Frequent Collaborators

5 joint publications

Hamideh Parhiz

4 joint publications

Haig Aghajanian

3 joint publications

Joel G Rurik

3 joint publications

Jonathan A Epstein